| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Investor Centre Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.01 |
| 52 Week High | AU$0.075 |
| 52 Week Low | AU$0.01 |
| Beta | -1.59 |
| 1 Month Change | -52.38% |
| 3 Month Change | n/a |
| 1 Year Change | -83.33% |
| 3 Year Change | -37.50% |
| 5 Year Change | n/a |
| Change since IPO | -69.70% |
Recent News & Updates
Recent updates
Shareholder Returns
| ICU | AU Capital Markets | AU Market | |
|---|---|---|---|
| 7D | -52.4% | 0.07% | -0.9% |
| 1Y | -83.3% | 10.4% | 8.7% |
Return vs Industry: ICU underperformed the Australian Capital Markets industry which returned 10.4% over the past year.
Return vs Market: ICU underperformed the Australian Market which returned 8.7% over the past year.
Price Volatility
| ICU volatility | |
|---|---|
| ICU Average Weekly Movement | n/a |
| Capital Markets Industry Average Movement | 4.3% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in AU Market | 17.3% |
| 10% least volatile stocks in AU Market | 3.3% |
Stable Share Price: ICU's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine ICU's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | n/a | Jody Elliss | www.birfinancial.com.au |
Investor Centre Limited operates as a financial services company in Australia. It offers equities and derivatives transacting, and capital raising financial services to retail, institutional, corporate, and private clients. The company was formerly known as BIR Financial Limited and changed its name to Investor Centre Limited in November 2023.
Investor Centre Limited Fundamentals Summary
| ICU fundamental statistics | |
|---|---|
| Market cap | AU$3.05m |
| Earnings (TTM) | -AU$2.14m |
| Revenue (TTM) | AU$294.16k |
8.3x
P/S Ratio-1.1x
P/E RatioIs ICU overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ICU income statement (TTM) | |
|---|---|
| Revenue | AU$294.16k |
| Cost of Revenue | AU$175.34k |
| Gross Profit | AU$118.82k |
| Other Expenses | AU$2.26m |
| Earnings | -AU$2.14m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.007 |
| Gross Margin | 40.39% |
| Net Profit Margin | -726.69% |
| Debt/Equity Ratio | -102.7% |
How did ICU perform over the long term?
See historical performance and comparison